Skip to main content

Table 1

From: One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)

*median

baseline

3 M

12 M

SJC

2.54

0.64

0

TJC

2.61

1.07

0.07

LRMC

2.14

1.57

0.92